InvestSMART

Bio-Gene Technology Ltd (ASX: BGT) - Announcements

- Current share price for BGT : $0.014

ASX company news and announcements for Bio-Gene Technology Ltd (BGT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bio-Gene Technology Ltd (BGT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bio-Gene Technology Ltd (BGT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bio-Gene Technology Ltd (BGT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 2018 AGM - CEO Presentation 20 Nov 2018 10:51AM $0.150 $0.014 fallen by 90.67%
$6 Appendix 4C - 30 September 2018 25 Oct 2018 12:24PM $0.170 $0.014 fallen by 91.76%
$6 Notice of Annual General Meeting/Proxy Form 16 Oct 2018 8:41AM $0.150 $0.014 fallen by 90.67%
$6 Change of Registered Office 15 Oct 2018 4:21PM $0.150 $0.014 fallen by 90.67%
$6 Company Update Presentation - October 2018 15 Oct 2018 10:06AM $0.135 $0.014 fallen by 89.63%
$6 IMPROVED MANUFACTURING PROCESS FOR FLAVOCIDE 11 Oct 2018 9:43AM $0.130 $0.014 fallen by 89.23%
$6 POSITIVE RESULTS FROM 28-DAY TOXICOLOGY STUDY ON FLAVOCIDE 9 Oct 2018 8:45AM $0.125 $0.014 fallen by 88.80%
$6 Appendix 3B - Release of Shares from Escrow 2 Oct 2018 3:54PM $0.125 $0.014 fallen by 88.80%
$6 Change of Registry Address: Automic P/L - Sydney Office 28 Sep 2018 12:27PM $0.130 $0.014 fallen by 89.23%
$6 Upcoming Release of Shares from Escrow 14 Sep 2018 3:25PM $0.135 $0.014 fallen by 89.63%
$6 POSITIVE RESULTS FOR FLAVOCIDE IN INITIAL FIELD TESTING 12 Sep 2018 8:52AM $0.130 $0.014 fallen by 89.23%
$6 POSITIVE EFFICACY RESULTS FOR FLAVOCIDE IN NEW PEST TYPES 5 Sep 2018 8:25AM $0.130 $0.014 fallen by 89.23%
$6 BGT 2018 Corporate Governance Statement 23 Aug 2018 8:22AM $0.125 $0.014 fallen by 88.80%
$6 Appendix 4G - 2018 23 Aug 2018 8:21AM $0.125 $0.014 fallen by 88.80%
$6 BGT 2018 Appendix 4E and Annual Report 23 Aug 2018 8:21AM $0.125 $0.014 fallen by 88.80%
$6 Appendix 3B - Release of Shares from Escrow 26 Jul 2018 3:04PM $0.135 $0.014 fallen by 89.63%
$6 Appendix 4C - 30 June 2018 26 Jul 2018 9:32AM $0.145 $0.014 fallen by 90.34%
$6 POSITIVE RESULTS FOR FLAVOCIDE IN SAFETY STUDY 23 Jul 2018 9:50AM $0.135 $0.014 fallen by 89.63%
$6 BIO-GENE SUBMITS TWO NEW INTERNATIONAL PATENT APPLICATIONS 10 Jul 2018 9:53AM $0.170 $0.014 fallen by 91.76%
$6 Qcide advancement - new results and research collaboration 3 Jul 2018 9:12AM $0.170 $0.014 fallen by 91.76%
$6 Upcoming Release of Shares from Escrow 29 Jun 2018 3:33PM $0.160 $0.014 fallen by 91.25%
$6 Appendix 3B - Release of Shares from Escrow 29 Jun 2018 3:31PM $0.160 $0.014 fallen by 91.25%
$6 EXPANSION OF FLAVOCIDE MODE OF ACTION STUDIES 26 Jun 2018 8:21AM $0.170 $0.014 fallen by 91.76%
$6 BEE SAFETY STUDY DELIVERS POSITIVE FINDINGS FOR FLAVOCIDE 18 Jun 2018 8:23AM $0.190 $0.014 fallen by 92.63%
$6 Upcoming Release of Shares from Escrow 13 Jun 2018 4:15PM $0.175 $0.014 fallen by 92%

401 - 425 of 480 results

Page 17 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.